๐ผ ๐๐ค๐ข๐ข๐ช๐ฃ๐๐ฉ๐ฎ-๐ก๐๐ ๐ฅ๐จ๐ฎ๐๐๐ค๐จ๐ค๐๐๐๐ก ๐จ๐ช๐ง๐ซ๐๐ฎ ๐๐๐ค๐ช๐ฉ ๐๐๐ ๐ง๐๐ข๐๐จ๐จ๐๐ค๐ฃ ๐๐๐ข๐จ ๐ฉ๐ค ๐๐จ๐จ๐๐จ๐จ ๐ฉ๐๐ ๐ ๐ฃ๐ค๐ฌ๐ก๐๐๐๐ ๐๐ฃ๐ ๐๐ญ๐ฅ๐๐๐ฉ๐๐ฉ๐๐ค๐ฃ๐จ ๐๐ข๐ค๐ฃ๐ ๐ฅ๐๐ค๐ฅ๐ก๐ ๐ก๐๐ซ๐๐ฃ๐ ๐ฌ๐๐ฉ๐ ๐๐๐
Are you a person living with #HIV based in Belgium, Denmark, France or Spain?
The European AIDS Treatment Group (EATG), HIV community partner within the #HIVACAR initiative, invites you to fill in ๐ ๐จ๐ช๐ง๐ซ๐๐ฎ to help better understand ๐ฎ๐ค๐ช๐ง ๐ ๐ฃ๐ค๐ฌ๐ก๐๐๐๐ ๐๐๐ค๐ช๐ฉ ๐๐๐ ๐ง๐๐ข๐๐จ๐จ๐๐ค๐ฃ (โfunctional cureโ) and ๐ฎ๐ค๐ช๐ง ๐๐ญ๐ฅ๐๐๐ฉ๐๐ฉ๐๐ค๐ฃ๐จ from the research for an intervention that could enable the control of HIV infection without taking medicines every day.
The survey takes about 1๏ธ0๏ธ minutes to fill in. It is available in English, Dutch, Danish, French and Spanish:
Danish: https://www.1ka.si/a/186891
Dutch: https://www.1ka.si/a/186843
English: https://www.1ka.si/a/179609
French: https://www.1ka.si/a/182281
Spanish: https://www.1ka.si/a/182262
The survey is strictly anonymous and the data will be treated with confidentiality. The results will be reported in a way that they cannot be traced back to any individual.
This survey is conducted within the framework of the HIVACAR project, funded by the European Commissionโs H2020 programme.
The HIVACAR project also seeks to investigate new therapeutic alternatives to โcART for lifeโ (combination Antiretroviral Therapy). ๐ผ ๐๐ก๐๐ฃ๐๐๐๐ก ๐ฉ๐ง๐๐๐ก investigating a patient-tailored, safe, affordable and scalable innovative intervention that potentially could help controlling HIV infection even without antiretroviral treatment will be conducted in three European countries. The recruiting clinical sites are:
- Hospital Clรญnic de Barcelona (Spain),
- Hospital Germans Trias i Pujol Badalona (Spain),
- Assistance Publique Hรดpitaux de Paris (France) and
- Vrije Universiteit Brussel (Belgium).
You can access more information regarding community participation to HIVACAR here:ย ย http://www.hivacar.org/community/
If you have further questions about the psychosocial survey or would like to receive more information about the clinical trial, please contact us at the EATG at ๐ฅ๐ง๐ค๐๐๐๐ฉ๐จ@๐๐๐ฉ๐.๐ค๐ง๐.
Thank you in advance for your participation and support.
Recent Comments